Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0315689 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Amr Sayed Ghanem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Informatics, Faculty of Health Sciences, University of Debrecen, Debrecen, Hungary. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aim Hungary has the fifth highest cancer incidence rate in the European Union, with an age-standardized rate (ASR) of 336.7 per 100,000 according to GLOBOCAN 2022. Additionally, Hungary holds the highest cancer mortality rate in the EU, with an ASR of 148.1 per 100,000. This study aimed to investigate the sociodemographic, lifestyle, and chronic disease-related factors affecting cancer prevalence in the Hungarian population. Materials and methods Data from the 2009, 2014, and 2019 installments of the European Health Interview Survey conducted in Hungary were pooled, resulting in a representative sample of 16,480 individuals. Weighted multiple logistic regression models were used to analyze the data, with goodness of fit assessed using the Hosmer-Lemeshow test. The best-fitting models were further evaluated using ROC analysis to calculate the Area Under the Curve (AUC) to assess discriminative ability.
Results
Urban residency was associated with higher cancer odds in 2014 (OR 1.85 [CI: 1.08–3.16]) and the pooled data (OR 1.44 [CI: 1.08–1.9]). Employed individuals had lower odds of cancer (2014: OR 0.34 [CI: 0.16–0.74]; pooled: OR 0.64 [CI: 0.45–0.92]). Among comorbid conditions, peptic ulcer (2009: OR 1.74 [CI: 1.13–2.69]; 2019: OR 3.2 [CI: 1.58–6.47]; pooled: OR 1.83 [CI: 1.31–2.54]) and chronic liver disease (2009: OR 3.52 [CI: 1.73–7.17]; pooled: OR 2.5 [CI: 1.4–4.47]) were significantly associated with higher cancer odds. Reporting bad health was linked to increased cancer risk (2009: OR 2.92 [CI: 1.87–4.58]; 2014: OR 5.52 [CI: 3.23–9.45]; 2019: OR 2.23 [CI: 1.26–3.95]).
Conclusion
Comorbid conditions such as peptic ulcer and chronic liver disease significantly increase cancer risk in Hungary. Urban residents require targeted preventive measures, and unemployment should be addressed. Early detection through appropriate screening and effective management of comorbid conditions are essential to prevent escalation and reduce overall cancer prevalence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Informatics, Faculty of Health Sciences, University of Debrecen, Debrecen, Hungary.
- Department of Integrative Health Sciences, Faculty of Health Sciences, University of Debrecen, Debrecen, Hungary.
- Institute of Social and Sociological Sciences, Faculty of Health Sciences, University of Debrecen, Nyíregyháza, Hungary.
ORCID-Profile: Amr Sayed Ghanem, Ágnes Tóth, Attila Csaba Nagy
Zitieren
APA
Ghanem, A. S., Faludi, E. V., Bata, R., Mezei, E., Hadar, V., Móré, M., Tóth, Á., & Nagy, A. C. (2025). Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys. PLOS ONE. https://doi.org/10.1371/journal.pone.0315689
Vancouver
Ghanem AS, Faludi EV, Bata R, Mezei E, Hadar V, Móré M, et al. Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys. PLOS ONE. 2025. doi:10.1371/journal.pone.0315689
BibTeX
@article{Ghanem2025,
author = {Ghanem, Amr Sayed and Faludi, Eszter Vargáné and Bata, Róbert and Mezei, Emese and Hadar, Vanessza and Móré, Marianna and Tóth, Ágnes and Nagy, Attila Csaba},
title = {Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0315689}
}
EUVIMED